MA53546A - Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide - Google Patents

Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide

Info

Publication number
MA53546A
MA53546A MA053546A MA53546A MA53546A MA 53546 A MA53546 A MA 53546A MA 053546 A MA053546 A MA 053546A MA 53546 A MA53546 A MA 53546A MA 53546 A MA53546 A MA 53546A
Authority
MA
Morocco
Prior art keywords
sulfamide
structured
kinase inhibitor
saline forms
novel hydrochloride
Prior art date
Application number
MA053546A
Other languages
English (en)
Inventor
David Jonaitis
Oskari Karjalainen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of MA53546A publication Critical patent/MA53546A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/04—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA053546A 2018-09-06 2019-09-05 Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide MA53546A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20185743 2018-09-06

Publications (1)

Publication Number Publication Date
MA53546A true MA53546A (fr) 2021-12-15

Family

ID=67982092

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053546A MA53546A (fr) 2018-09-06 2019-09-05 Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide

Country Status (12)

Country Link
US (1) US11866420B2 (fr)
EP (1) EP3846906A1 (fr)
JP (1) JP7528060B2 (fr)
KR (1) KR20210057759A (fr)
CN (1) CN112805065B (fr)
AU (1) AU2019334693A1 (fr)
CA (1) CA3111040A1 (fr)
EA (1) EA202190696A1 (fr)
MA (1) MA53546A (fr)
MX (1) MX2021002524A (fr)
SG (1) SG11202102110PA (fr)
WO (1) WO2020049217A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3601262T3 (fi) * 2017-03-23 2023-01-13 Prosessi sulfonamidirakenteisen kinaasi-inhibiittorin valmistamiseksi
WO2021176146A1 (fr) * 2020-03-05 2021-09-10 Orion Corporation Compositions pharmaceutiques d'un inhibiteur de kinase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA111382C2 (uk) * 2011-10-10 2016-04-25 Оріон Корпорейшн Інгібітори протеїнкінази
FI3601262T3 (fi) * 2017-03-23 2023-01-13 Prosessi sulfonamidirakenteisen kinaasi-inhibiittorin valmistamiseksi
WO2020135878A1 (fr) * 2018-12-29 2020-07-02 南京明德新药研发有限公司 Dérivé d'imidazopyridine utilisé en tant qu'inhibiteur double de fgfr et vegfr
CN113993867B (zh) * 2019-06-14 2023-10-24 盛世泰科生物医药技术(苏州)股份有限公司 作为fgfr和vegfr双重抑制剂的并环类化合物

Also Published As

Publication number Publication date
EP3846906A1 (fr) 2021-07-14
WO2020049217A1 (fr) 2020-03-12
US20210332028A1 (en) 2021-10-28
EA202190696A1 (ru) 2021-06-16
KR20210057759A (ko) 2021-05-21
CN112805065B (zh) 2024-07-05
CN112805065A (zh) 2021-05-14
JP2022501328A (ja) 2022-01-06
SG11202102110PA (en) 2021-04-29
US11866420B2 (en) 2024-01-09
CA3111040A1 (fr) 2020-03-12
AU2019334693A1 (en) 2021-05-13
MX2021002524A (es) 2021-04-28
JP7528060B2 (ja) 2024-08-05

Similar Documents

Publication Publication Date Title
MA54458A (fr) Formes cristallines et formes salines d'un inhibiteur de kinase
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
BRPI0409063A (pt) pró medicamentos de inibidor de pi-3 cinase
MA53546A (fr) Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide
MA55801A (fr) Formes solides d'un inhibiteur de glyt1
UA42369S (uk) Комп'ютер
MA54526A (fr) NOUVELLES FORMES POLYMORPHES D'UN INHIBITEUR DE TGFBeta
MA53635A (fr) Utilisation d'un inhibiteur de la cathepsine s contre la formation d'anticorps anti-médicament
MA49774A (fr) Carton à témoin d'intégrité
ES1261716Y (es) "cubrecajas"
UA44582S (uk) Молоток столярний - киянка
CA206981S (fr) Boîtier d'ordinateur
CA206980S (fr) Boîtier d'ordinateur
UA39057S (uk) Солодощі «грильяж «мішутка»
UA43461S (uk) Умивальник «sorrento»
UA39682S (uk) Комплект етикеток «ludovic»
TH194045S (th) อิฐบล็อก
TH194044S (th) อิฐบล็อก
TH194035S (th) แปรงสีฟัน
UA44711S (uk) Розгортка упаковки для гель-бальзаму «суставит»
UA45272S (uk) Умивальник «marlen»
UA44689S (uk) Умивальник «teya»
UA45274S (uk) Умивальник «agness 1500»
UA44684S (uk) Умивальник «levanto 1280»
JP1761001S (ja) シャワーヘッド